Ching-Yuh Chern
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ching-Yuh Chern has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Yau-Hung Chen
Department of Chemistry, Tamkang University, New Taipei, Taiwan
6 shared publications - Chao-Yuan Chang
Institute for Physiological Chemistry, Medical Faculty Carl Gustav Carus, Technische Universität Dresden
2 shared publications Chi-Chung Wen
Institute of Public Health , National Yang Ming Chiao Tung University , Taipei , Taiwan , cam.ac.uk
2 shared publications- Ya-Ting Lee
Department of Chemistry, Tamkang University, 151, Ying-chuan Road, Danshui District, New Taipei City 25137, Taiwan
2 shared publications - Biswajit Mohanty
Multifunctional Molecular Materials Laboratory, Department of Chemistry, School of Natural Sciences, Shiv Nadar Institution of Eminence Deemed to be University, Delhi-NCR, Uttar Pradesh-201314, India
1 shared publication Bo-Jie Sun
Department of Chemistry, Tamkang University, Tamsui, Taiwan
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Toxicology
- Vol. 2026 (1) , 6939974
A Phenotype‐Driven Discovery of Pro‐Revascularization Chalcone Derivatives Using Zebrafish and CAM Models
Angiogenesis is crucial for tissue repair and the treatment of ischemic diseases, yet effective small‐molecule proangiogenic agents are lacking in clinical practice. Chalcone‐based compounds are of interest due to their diverse biological activities. This study aimed to synthesize and evaluate the proangiogenic potential of a series of novel chalcone derivatives and to elucidate their structure–activity relationship (SAR) using computational chemistry. We synthesized and tested six chalcone derivatives (1a–1f), with compound ( E )‐1‐(3,4‐dimethoxyphenyl)‐3‐(3‐hydroxy‐4‐methoxyphenyl)prop‐2‐en‐1‐one (1c) exhibiting the highest activity. In the zebrafish model, treatment with 1c significantly increased the formation of branch points and vessel outgrowth in the subintestinal vein (SIV) (number of branch points: 1c group 2.28 ± 0.19, control group 0.79 ± 0.17; p < 0.001). Using Tg( fli1:egfp ) transgenic zebrafish, we observed that 1c dramatically promoted the remodeling of the caudal vein plexus (CVP), leading to a significant increase in the number of intercapillary spaces (1c group 16.3 ± 1.9, mock group 11.6 ± 2). Mechanistically, real‐time polymerase chain reaction (RT‐PCR) results showed that 1c treatment upregulated the expression of key angiogenic genes cadherin 5 and neuropilin 1a, while downregulating the expression of fms‐related receptor tyrosine kinase 1. Furthermore, the chick embryo chorioallantoic membrane (CAM) assay confirmed that 1c effectively induced vascular network formation. Computational chemistry analyses (DFT, MESP, and FMO) were highly consistent with the biological activity. 1c possessed the highest electrophilicity index ( ω ), chemical potential ( μ ), and electron transfer capability (Δ N ), as well as the strongest electrophilic site ( V s ,max ), which explains its superior biological activity. This study confirms the potent proangiogenic activity of chalcone derivative 1c, providing a promising lead compound for the development of novel small‐molecule therapeutics targeting vascular dysfunction diseases.
- 1 January 2026
- Published by Wiley in Journal of Toxicology
- Vol. 2026 (1) , 6939974
Open AccessA Phenotype‐Driven Discovery of Pro‐Revascularization Chalcone Derivatives Using Zebrafish and CAM Models
Angiogenesis is crucial for tissue repair and the treatment of ischemic diseases, yet effective small‐molecule proangiogenic agents are lacking in clinical practice. Chalcone‐based compounds are of interest due to their diverse biological activities. This study aimed to synthesize and evaluate the proangiogenic potential of a series of novel chalcone derivatives and to elucidate their structure–activity relationship (SAR) using computational chemistry. We synthesized and tested six chalcone derivatives (1a–1f), with compound ( E )‐1‐(3,4‐dimethoxyphenyl)‐3‐(3‐hydroxy‐4‐methoxyphenyl)prop‐2‐en‐1‐one (1c) exhibiting the highest activity. In the zebrafish model, treatment with 1c significantly increased the formation of branch points and vessel outgrowth in the subintestinal vein (SIV) (number of branch points: 1c group 2.28 ± 0.19, control group 0.79 ± 0.17; p < 0.001). Using Tg( fli1:egfp ) transgenic zebrafish, we observed that 1c dramatically promoted the remodeling of the caudal vein plexus (CVP), leading to a significant increase in the number of intercapillary spaces (1c group 16.3 ± 1.9, mock group 11.6 ± 2). Mechanistically, real‐time polymerase chain reaction (RT‐PCR) results showed that 1c treatment upregulated the expression of key angiogenic genes cadherin 5 and neuropilin 1a, while downregulating the expression of fms‐related receptor tyrosine kinase 1. Furthermore, the chick embryo chorioallantoic membrane (CAM) assay confirmed that 1c effectively induced vascular network formation. Computational chemistry analyses (DFT, MESP, and FMO) were highly consistent with the biological activity. 1c possessed the highest electrophilicity index ( ω ), chemical potential ( μ ), and electron transfer capability (Δ N ), as well as the strongest electrophilic site ( V s ,max ), which explains its superior biological activity. This study confirms the potent proangiogenic activity of chalcone derivative 1c, providing a promising lead compound for the development of novel small‐molecule therapeutics targeting vascular dysfunction diseases.
- 19 February 2024
- Published by Elsevier in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
- Vol. 278, 109862
The angiogenesis-modulating effects of coumarin-derivatives
- 19 February 2024
- Published by Elsevier in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
- Vol. 278, 109862
The angiogenesis-modulating effects of coumarin-derivatives
- Open Access
Coumarin Derivatives Inhibit ADP-Induced Platelet Activation and Aggregation
Coumarin was first discovered in Tonka bean and then widely in other plants. Coumarin has an anticoagulant effect, and its derivative, warfarin, is a vitamin K analogue that inhibits the synthesis of clotting factors and is more widely used in the clinical treatment of endovascular embolism. At present, many artificial chemical synthesis methods can be used to modify the structure of coumarin to develop many effective drugs with low toxicity. In this study, we investigated the effects of six coumarin derivatives on the platelet aggregation induced by adenosine diphosphate (ADP). We found that the six coumarin derivatives inhibited the active form of GPIIb/IIIa on platelets and hence inhibit platelet aggregation. We found that 7-hydroxy-3-phenyl 4H-chromen-4-one (7-hydroxyflavone) had the most severe effect. In addition, we further analyzed the downstream signal transduction of the ADP receptor, including the release of calcium ions and the regulation of cAMP, which were inhibited by the six coumarin derivatives selected in this study. These results suggest that coumarin derivatives inhibit coagulation by inhibiting the synthesis of coagulation factors and they may also inhibit platelet aggregation.
Open AccessCoumarin Derivatives Inhibit ADP-Induced Platelet Activation and Aggregation
Coumarin was first discovered in Tonka bean and then widely in other plants. Coumarin has an anticoagulant effect, and its derivative, warfarin, is a vitamin K analogue that inhibits the synthesis of clotting factors and is more widely used in the clinical treatment of endovascular embolism. At present, many artificial chemical synthesis methods can be used to modify the structure of coumarin to develop many effective drugs with low toxicity. In this study, we investigated the effects of six coumarin derivatives on the platelet aggregation induced by adenosine diphosphate (ADP). We found that the six coumarin derivatives inhibited the active form of GPIIb/IIIa on platelets and hence inhibit platelet aggregation. We found that 7-hydroxy-3-phenyl 4H-chromen-4-one (7-hydroxyflavone) had the most severe effect. In addition, we further analyzed the downstream signal transduction of the ADP receptor, including the release of calcium ions and the regulation of cAMP, which were inhibited by the six coumarin derivatives selected in this study. These results suggest that coumarin derivatives inhibit coagulation by inhibiting the synthesis of coagulation factors and they may also inhibit platelet aggregation.
- Open Access
- 23 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4422
Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells
BRCA mutation, one of the most common types of mutations in breast and ovarian cancer, has been suggested to be synthetically lethal with depletion of RAD52. Pharmacologically inhibiting RAD52 specifically eradicates BRCA-deficient cancer cells. In this study, we demonstrated that curcumin, a plant polyphenol, sensitizes BRCA2-deficient cells to CPT-11 by impairing RAD52 recombinase in MCF7 cells. More specifically, in MCF7-siBRCA2 cells, curcumin reduced homologous recombination, resulting in tumor growth suppression. Furthermore, a BRCA2-deficient cell line, Capan1, became resistant to CPT-11 when BRCA2 was reintroduced. In vivo, xenograft model studies showed that curcumin combined with CPT-11 reduced the growth of BRCA2-knockout MCF7 tumors but not MCF7 tumors. In conclusion, our data indicate that curcumin, which has RAD52 inhibitor activity, is a promising candidate for sensitizing BRCA2-deficient cells to DNA damage-based cancer therapies.
- 23 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4422
Open AccessTargeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells
BRCA mutation, one of the most common types of mutations in breast and ovarian cancer, has been suggested to be synthetically lethal with depletion of RAD52. Pharmacologically inhibiting RAD52 specifically eradicates BRCA-deficient cancer cells. In this study, we demonstrated that curcumin, a plant polyphenol, sensitizes BRCA2-deficient cells to CPT-11 by impairing RAD52 recombinase in MCF7 cells. More specifically, in MCF7-siBRCA2 cells, curcumin reduced homologous recombination, resulting in tumor growth suppression. Furthermore, a BRCA2-deficient cell line, Capan1, became resistant to CPT-11 when BRCA2 was reintroduced. In vivo, xenograft model studies showed that curcumin combined with CPT-11 reduced the growth of BRCA2-knockout MCF7 tumors but not MCF7 tumors. In conclusion, our data indicate that curcumin, which has RAD52 inhibitor activity, is a promising candidate for sensitizing BRCA2-deficient cells to DNA damage-based cancer therapies.
- 15 January 2020
- Published by Wiley in Journal of the Chinese Chemical Society
- Vol. 67 (3) , 422-429
The inhibition profiles of 4'‐acylpyrrole–5‐fluoroindolin‐2‐ones with a C‐3' side chain for VEGFR2, PDGFR‐β, and FGFR‐1 protein kinases
In this study, we reported the inhibition profiles of 4′‐acylpyrrole–5‐fluoroindolin‐2‐one 3 with a C‐3′ side chain for VEGFR2, PDGFR‐β, and FGFR‐1 protein kinases. The pyrrole‐fused cyclohexanone moiety provided 3 with the best potency to inhibit the three kinases, and the C‐3′ side chains contributed to the different inhibition profiles of 3. Compound 3b with a C‐3′ 2‐carboxylethyl side chain showed good potency for the three kinase (IC50: 25–260 nM), and compound 3g with a N,N‐dialkyl‐2‐carbamoylethyl side chain was more active for VEGFR2 (IC50: 59 nM) and PDGFR‐β (IC50: 16 nM) than FGFR‐1 (IC50: 1.7 μM). The C‐3′ 3‐(dialkylamino)propyl side chain accomplished 3h–j as selective PDGFR‐β inhibitors (IC50: 7.8–13 nM). Compound 3b was further investigated and found potent to inhibit VEGF‐ and FGF‐dependent cell proliferation with moderate in vivo anticancer activity. Results from docking simulations revealed that the interactions of 3b with VEGFR2 and FGFR‐1 which could account for the different inhibition profiles of 3.
- 15 January 2020
- Published by Wiley in Journal of the Chinese Chemical Society
- Vol. 67 (3) , 422-429
The inhibition profiles of 4'‐acylpyrrole–5‐fluoroindolin‐2‐ones with a C‐3' side chain for VEGFR2, PDGFR‐β, and FGFR‐1 protein kinases
In this study, we reported the inhibition profiles of 4′‐acylpyrrole–5‐fluoroindolin‐2‐one 3 with a C‐3′ side chain for VEGFR2, PDGFR‐β, and FGFR‐1 protein kinases. The pyrrole‐fused cyclohexanone moiety provided 3 with the best potency to inhibit the three kinases, and the C‐3′ side chains contributed to the different inhibition profiles of 3. Compound 3b with a C‐3′ 2‐carboxylethyl side chain showed good potency for the three kinase (IC50: 25–260 nM), and compound 3g with a N,N‐dialkyl‐2‐carbamoylethyl side chain was more active for VEGFR2 (IC50: 59 nM) and PDGFR‐β (IC50: 16 nM) than FGFR‐1 (IC50: 1.7 μM). The C‐3′ 3‐(dialkylamino)propyl side chain accomplished 3h–j as selective PDGFR‐β inhibitors (IC50: 7.8–13 nM). Compound 3b was further investigated and found potent to inhibit VEGF‐ and FGF‐dependent cell proliferation with moderate in vivo anticancer activity. Results from docking simulations revealed that the interactions of 3b with VEGFR2 and FGFR‐1 which could account for the different inhibition profiles of 3.
- Open Access
Chalcone Derivatives Enhance ATP-Binding Cassette Transporters A1 in Human THP-1 Macrophages
Atherosclerosis is a process of imbalanced lipid metabolism in the vascular walls. The underlying pathology mainly involves the deposition of oxidized lipids in the endothelium and the accumulation of cholesterol in macrophages. Macrophages export excessive cholesterol (cholesterol efflux) through ATP-binding cassette transporter A1 (ABCA1) to counter the progression of atherosclerosis. We synthesized novel chalcone derivatives and assessed their effects and the underlying mechanisms on ABCA1 expression in macrophages. Human THP-1 macrophages were treated with synthetic chalcone derivatives for 24 h. In Western blot and flow cytometry analyses, a chalcone derivative, (E)-1-(3,4-diisopropoxyphenyl)-3-(4-isopropoxy-3-methoxyphenyl)prop- 2-en-1-one (1m), was observed to significantly enhance ABCA1 protein expression in THP-1 cells (10 µM, 24 h). Levels of mRNA of ABCA1 and liver X receptor alpha (LXRα) were quantified using a real-time quantitative polymerase chain reaction technique and were found to be significantly increased after treatment with the novel chalcone derivative 1m. Several microRNAs, including miR155, miR758, miR10b, miR145, miR33, and miR106b, which functionally inhibit ABCA1 expression were suppressed after treatment with 1m. Collectively, 1m increases ABCA1 expression in human THP-1 macrophages. The mechanisms involve the activation of the LXRα-ABCA1 pathway and suppression of certain microRNAs that regulate ABCA1 expression.
Open AccessChalcone Derivatives Enhance ATP-Binding Cassette Transporters A1 in Human THP-1 Macrophages
Atherosclerosis is a process of imbalanced lipid metabolism in the vascular walls. The underlying pathology mainly involves the deposition of oxidized lipids in the endothelium and the accumulation of cholesterol in macrophages. Macrophages export excessive cholesterol (cholesterol efflux) through ATP-binding cassette transporter A1 (ABCA1) to counter the progression of atherosclerosis. We synthesized novel chalcone derivatives and assessed their effects and the underlying mechanisms on ABCA1 expression in macrophages. Human THP-1 macrophages were treated with synthetic chalcone derivatives for 24 h. In Western blot and flow cytometry analyses, a chalcone derivative, (E)-1-(3,4-diisopropoxyphenyl)-3-(4-isopropoxy-3-methoxyphenyl)prop- 2-en-1-one (1m), was observed to significantly enhance ABCA1 protein expression in THP-1 cells (10 µM, 24 h). Levels of mRNA of ABCA1 and liver X receptor alpha (LXRα) were quantified using a real-time quantitative polymerase chain reaction technique and were found to be significantly increased after treatment with the novel chalcone derivative 1m. Several microRNAs, including miR155, miR758, miR10b, miR145, miR33, and miR106b, which functionally inhibit ABCA1 expression were suppressed after treatment with 1m. Collectively, 1m increases ABCA1 expression in human THP-1 macrophages. The mechanisms involve the activation of the LXRα-ABCA1 pathway and suppression of certain microRNAs that regulate ABCA1 expression.
- Open Access
Pro-Angiogenic Effects of Chalcone Derivatives in Zebrafish Embryos in Vivo
The aim of this study was to investigate novel chalcones with potent angiogenic activities in vivo. Chalcone-based derivatives were evaluated using a transgenic zebrafish line with fluorescent vessels to real-time monitor the effect on angiogenesis. Results showed that the chalcone analogues did not possess anti-angiogenic effect on zebrafish vasculatures; instead, some of them displayed potent pro-angiogenic effects on the formation of the sub-intestinal vein. Similar pro-angiogenic effects can also be seen on wild type zebrafish embryos. Moreover, the expression of vegfa, the major regulator for angiogenesis, was also upregulated in their treatment. Taken together, we have synthesized and identified a series of novel chalcone-based derivatives as potent in vivo pro-angiogenic compounds. These novel compounds hold potential for therapeutic angiogenesis.
Open AccessPro-Angiogenic Effects of Chalcone Derivatives in Zebrafish Embryos in Vivo
The aim of this study was to investigate novel chalcones with potent angiogenic activities in vivo. Chalcone-based derivatives were evaluated using a transgenic zebrafish line with fluorescent vessels to real-time monitor the effect on angiogenesis. Results showed that the chalcone analogues did not possess anti-angiogenic effect on zebrafish vasculatures; instead, some of them displayed potent pro-angiogenic effects on the formation of the sub-intestinal vein. Similar pro-angiogenic effects can also be seen on wild type zebrafish embryos. Moreover, the expression of vegfa, the major regulator for angiogenesis, was also upregulated in their treatment. Taken together, we have synthesized and identified a series of novel chalcone-based derivatives as potent in vivo pro-angiogenic compounds. These novel compounds hold potential for therapeutic angiogenesis.
- Open Access
- 4 March 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (3) , 3926-3951
Synthesis of Analogues of Gingerol and Shogaol, the Active Pungent Principles from the Rhizomes of Zingiber officinale and Evaluation of Their Anti-Platelet Aggregation Effects
The present study was aimed at discovering novel biologically active compounds based on the skeletons of gingerol and shogaol, the pungent principles from the rhizomes of Zingiber officinale. Therefore, eight groups of analogues were synthesized and examined for their inhibitory activities of platelet aggregation induced by arachidonic acid, collagen, platelet activating factor, and thrombin. Among the tested compounds, [6]-paradol (5b) exhibited the most significant anti-platelet aggregation activity. It was the most potent candidate, which could be used in further investigation to explore new drug leads.
- 4 March 2014
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 15 (3) , 3926-3951
Open AccessSynthesis of Analogues of Gingerol and Shogaol, the Active Pungent Principles from the Rhizomes of Zingiber officinale and Evaluation of Their Anti-Platelet Aggregation Effects
The present study was aimed at discovering novel biologically active compounds based on the skeletons of gingerol and shogaol, the pungent principles from the rhizomes of Zingiber officinale. Therefore, eight groups of analogues were synthesized and examined for their inhibitory activities of platelet aggregation induced by arachidonic acid, collagen, platelet activating factor, and thrombin. Among the tested compounds, [6]-paradol (5b) exhibited the most significant anti-platelet aggregation activity. It was the most potent candidate, which could be used in further investigation to explore new drug leads.
- Open Access
Toxicity Assessments of Chalcone and Some Synthetic Chalcone Analogues in a Zebrafish Model
The aim of this study was to investigate the in vivo toxicities of some novel synthetic chalcones. Chalcone and four chalcone analogues 1a–d were evaluated using zebrafish embryos following antibody staining to visualize their morphological changes and muscle fiber alignment. Results showed that embryos treated with 3'-hydroxychalcone (compound 1b) displayed a high percentage of muscle defects (96.6%), especially myofibril misalignment. Ultrastructural analysis revealed that compound 1b-treated embryos displayed many muscle defect phenotypes, including breakage and collapse of myofibrils, reduced cell numbers, and disorganized thick (myosin) and thin (actin) filaments. Taken together, our results provide in vivo evidence of the myotoxic effects of the synthesized chalcone analogues on developing zebrafish embryos.
Open AccessToxicity Assessments of Chalcone and Some Synthetic Chalcone Analogues in a Zebrafish Model
The aim of this study was to investigate the in vivo toxicities of some novel synthetic chalcones. Chalcone and four chalcone analogues 1a–d were evaluated using zebrafish embryos following antibody staining to visualize their morphological changes and muscle fiber alignment. Results showed that embryos treated with 3'-hydroxychalcone (compound 1b) displayed a high percentage of muscle defects (96.6%), especially myofibril misalignment. Ultrastructural analysis revealed that compound 1b-treated embryos displayed many muscle defect phenotypes, including breakage and collapse of myofibrils, reduced cell numbers, and disorganized thick (myosin) and thin (actin) filaments. Taken together, our results provide in vivo evidence of the myotoxic effects of the synthesized chalcone analogues on developing zebrafish embryos.
- Open Access
Evaluation of the Anti-Inflammatory Effect of Chalcone and Chalcone Analogues in a Zebrafish Model
The aim of this study was to investigate novel chalcones with potent anti-inflammatory activities in vivo. Chalcone and two chalcone analogues (compound 5 and 9) were evaluated using a caudal fin-wounded transgenic zebrafish line “Tg(mpx:gfp)” to visualize the effect of neutrophil recruitment dynamically. Results showed that treatment with compound 9 not only affected wound-induced neutrophil recruitment, but also affected Mpx enzymatic activity. Moreover, protein expression levels of pro-inflammatory factors (Mpx, NFκB, and TNFα) were also regulated by compound 9. Taken together, our results provide in vivo evidence of the anti-inflammatory effects of synthesized chalcone analogues on wound-induced inflammation.
Open AccessEvaluation of the Anti-Inflammatory Effect of Chalcone and Chalcone Analogues in a Zebrafish Model
The aim of this study was to investigate novel chalcones with potent anti-inflammatory activities in vivo. Chalcone and two chalcone analogues (compound 5 and 9) were evaluated using a caudal fin-wounded transgenic zebrafish line “Tg(mpx:gfp)” to visualize the effect of neutrophil recruitment dynamically. Results showed that treatment with compound 9 not only affected wound-induced neutrophil recruitment, but also affected Mpx enzymatic activity. Moreover, protein expression levels of pro-inflammatory factors (Mpx, NFκB, and TNFα) were also regulated by compound 9. Taken together, our results provide in vivo evidence of the anti-inflammatory effects of synthesized chalcone analogues on wound-induced inflammation.